ISPE Announces 2025-2026 ISPE International Board of Directors Election Results
The 2025–2026 ISPE International Board of Directors has been announced. Newly elected Directors will assume their positions at the 2025 ISPE Annual Meeting & Expo.
ISPE has announced the results of the 2025–2026 ISPE International Board of Directors election.
The ISPE International Board of Directors is responsible for the governance and strategic direction of ISPE. Board members will assume their elected positions at the 2025 ISPE Annual Meeting & Expo, taking place in Charlotte, North Carolina, USA, and virtually from 26 to 29 October.
The following pharmaceutical industry leaders have been elected to positions on the 2025–2026 ISPE International Board of Directors.
Executive Committee:
Elected to a Second Term:
New Directors:
Board Members Continuing a Term in 2025-2026:
The following Directors were elected in 2024 to serve a two-year term and will continue their service on the Board in 2025-2026:
Board Members Completing Service:
The election was run by an independent third party, which provided ISPE with the final audited results.
Learn more about ISPE.
Register for the upcoming 2025 ISPE Annual Meeting & Expo.
About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 23,000+ members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory, and compliance collaborations in more than 120 countries worldwide. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. For more information, visit ISPE.org.